Allows for Commercial Deployment of the Company's Radiation-Free Breast Imaging Technology Under Distribution Agreement with Gulf Medical Co.

QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its Breast Acoustic CT™ scanner has received official classification and clearance from the Kingdom of Saudi Arabia (KSA) for use as a medical device in that country.

The Saudi Food and Drug Authority (SFDA) approval allows QT Imaging's Breast Acoustic CT™ scanner to be marketed, sold, and deployed throughout Saudi Arabia, one of the largest healthcare markets in the Middle East. The approval marks a significant milestone in the Company's international expansion strategy and further strengthens its growing commercial presence across the Gulf region.

In August 2025, QT Imaging entered into an exclusive distribution agreement with Gulf Medical Co., a leading provider of healthcare technologies in Saudi Arabia. With SFDA approval now secured, Gulf Medical is positioned to begin commercial activities and engage healthcare institutions throughout the Kingdom.

Saudi Arabia continues to invest heavily in healthcare modernization and women's health initiatives as part of Vision 2030 and its Health Sector Transformation Program, which aims to improve healthcare access, quality, preventive care, and digital health infrastructure across the Kingdom.(1) Breast cancer remains the most commonly diagnosed cancer among women in the Kingdom,(2) creating an increasing demand for advanced, patient friendly imaging technologies that improve access to screening and diagnostic services.